Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Net Income: 2020-2025

Historic Net Income for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to -$2.8 million.

  • iSpecimen's Net Income fell 65.34% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.3 million, marking a year-over-year decrease of 26.75%. This contributed to the annual value of -$12.9 million for FY2024, which is 18.55% down from last year.
  • Latest data reveals that iSpecimen reported Net Income of -$2.8 million as of Q3 2025, which was down 55.40% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Net Income registered a high of -$1.6 million during Q3 2021, and its lowest value of -$6.0 million during Q4 2024.
  • Moreover, its 3-year median value for Net Income was -$2.4 million (2023), whereas its average is -$2.7 million.
  • As far as peak fluctuations go, iSpecimen's Net Income slumped by 141.97% in 2021, and later soared by 44.95% in 2025.
  • Over the past 5 years, iSpecimen's Net Income (Quarterly) stood at -$2.0 million in 2021, then fell by 6.51% to -$2.2 million in 2022, then crashed by 30.96% to -$2.8 million in 2023, then crashed by 111.96% to -$6.0 million in 2024, then crashed by 65.34% to -$2.8 million in 2025.
  • Its Net Income stands at -$2.8 million for Q3 2025, versus -$1.8 million for Q2 2025 and -$1.6 million for Q1 2025.